Related Experiment Video

Updated: May 18, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

[The potential nephrotoxicity of antiretroviral drugs]

Zofia Marchewka1, Beata Szymańska, Joanna Płonka

  • 1Pracownia Markerów Nefrotoksyczności Środowiskowej, Katedra i Zakład Toksykologii Uniwersytetu Medycznego im. Piastów Śląskich we Wrocławiu, ul. Borowska 211, 50-556 Wrocław, Poland. zofia.marchewka@am.wroc.pl

Postepy Higieny I Medycyny Doswiadczalnej (Online)
|September 25, 2012
PubMed

Insights

Antiretroviral drugs effectively inhibit HIV, but long-term use can cause kidney damage. This review details common nephrotoxic drugs, HIV-related kidney disease, and genetic influences on kidney pathology.

Area of Science:

  • Nephrology
  • Infectious Diseases
  • Pharmacology

Background:

  • Antiretroviral therapies have significantly advanced HIV treatment, inhibiting viral replication.
  • Long-term use of these essential medications can lead to substantial patient side effects.
  • Kidney complications are a serious concern in patients with HIV and those undergoing treatment.

Purpose of the Study:

  • To review antiretroviral drugs with known nephrotoxicity potential commonly used in clinical practice.
  • To examine nephropathy directly caused by HIV infection.
  • To explore the role of genetic factors in the development of kidney pathology.

Main Methods:

  • Literature review of scientific studies and clinical practice data.
  • Analysis of drug profiles for nephrotoxicity.
  • Examination of research on HIV-associated nephropathy (HIVAN).
  • Investigation into genetic predispositions for kidney disease.

Main Results:

  • Several commonly prescribed antiretroviral agents possess significant nephrotoxicity.
  • HIV infection itself can independently cause progressive kidney damage.
  • Genetic variations can influence an individual's susceptibility to kidney damage from HIV and its treatment.

Conclusions:

  • Careful monitoring for kidney function is crucial in patients on long-term antiretroviral therapy.
  • Understanding the interplay between HIV, antiretroviral drugs, and host genetics is vital for managing nephropathy.
  • Further research into genetic factors may enable personalized treatment strategies to mitigate kidney risks.

More Related Videos

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Cellular Redox Profiling Using High-content Microscopy11:37

Cellular Redox Profiling Using High-content Microscopy

Published on: May 14, 2017

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug toxicity: Drug–Drug Interaction01:30

Drug toxicity: Drug–Drug Interaction

Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
Pharmacokinetics: Drug–Food and Drug–Viral Interactions01:26

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of many...